Showing 1651-1660 of 2105 results for "".
- When Life Is "Fragrance-Free" — Taste & Smell Disorders In Clinical Neurologyhttps://practicalneurology.com/columns/practice-management/when-life-is-fragrance-free-taste-smell-disorders-in-clinical-neurology/31067/Taste and Smell Disorders: Emerging Concerns in Clinical NeurologyTaste and smell disorders are increasingly recognized within clinical neurology, expanding beyond their traditional focus in otorhino-laryngology. Dr. Ronald Devere underscores the rising prevalence of these sensory impairments in var
- News Briefshttps://practicalneurology.com/columns/practice-management/news-briefs/31065/Recent studies highlighted in Practical Neurology’s January 2008 issue provide significant insights into neurological conditions and their broader health implications. Notably, research published in Neurology reveals that patients with Restless Legs Syndrome (RLS) face double the risk of stroke and
- Epilepsy Essentialshttps://practicalneurology.com/diseases-diagnoses/epilepsy-seizures/pn0108Epilepsy-pdf/31069/Predicting Seizures: Enhancing Epilepsy Management through Clinical InsightsEpilepsy remains a challenging neurological disorder, primarily due to the unpredictability of seizure occurrences. Despite the widespread use of anti-epileptic drugs (AEDs), approximately 40% of patients continue to experie
- Editor's Messagehttps://practicalneurology.com/columns/practice-management/editors-message/31062/Practical Neurology continues to serve as a vital resource for healthcare professionals in the neurology field, emphasizing both clinical excellence and effective practice management. In the January 2008 issue, Editor-in-Chief Jack Persico highlights the critical importance of communication between
- News Briefshttps://practicalneurology.com/columns/practice-management/news-briefs/31118/Recent advancements in neurology highlight significant progress and emerging insights into Alzheimer’s disease (AD) and related neurological conditions. A pivotal study published in the FASEB Journal reveals that amyloid β-derived diffusible ligand (ADDL) in AD patients disrupts insulin signaling by
- What Should We Do About Asymptomatic AVMs?https://practicalneurology.com/columns/practice-management/what-should-we-do-about-asymptomatic-avms/31127/Clinical Decision-Making in the Management of Asymptomatic Cerebral Arteriovenous MalformationsCerebral arteriovenous malformations (AVMs) present a significant clinical challenge, especially when asymptomatic. The primary dilemma revolves around balancing the natural hemorrhage risk against the pot
- Seizures, AEDs and Pregnancy: A Dangerous Combinationhttps://practicalneurology.com/diseases-diagnoses/epilepsy-seizures/pn0407-epilepsy-pdf/31188/Managing epilepsy in women who are pregnant or planning pregnancy presents significant challenges for neurologists. Seizures during pregnancy pose risks to both the mother and the unborn child, while the use of anti-epileptic drugs (AEDs) can lead to congenital malformations and potential cognitive
- Business Advisorhttps://practicalneurology.com/columns/practice-management/business-advisor/31185/Navigating Compensation Challenges in Neurology PracticeRecent analyses reveal a concerning trend for physicians across all medical specialties, including neurology: compensation growth is lagging behind productivity increases and inflation. According to the Medical Group Management Association’s (M
- What if the Patient Doesn’t Care?https://practicalneurology.com/diseases-diagnoses/alzheimer-disease-dementias/pn0307-dementia-pdf/31198/In the article "What if the Patient Doesn’t Care?" by Dr. David S. Geldmacher, the complex interplay between apathy and Alzheimer’s disease (AD) is explored through the case study of Anthony and Marie. Following Anthony’s retirement, Marie noticed a marked decline in his motivation and engagement, w
- Movement Disorders Focushttps://practicalneurology.com/diseases-diagnoses/movement-disorders/pn0207-movement-pdf/31216/Movement disorders significantly impair patients’ daily activities and quality of life, necessitating objective assessment tools for both clinical practice and research. Practical Neurology’s two-part series delves into the utilization and evaluation of popular rating scales for various movement dis